Placebo-controlled trial of oral enoximone in end-stage congestive heart failure refractory to optimal treatment
- 31 July 1990
- journal article
- clinical trial
- Published by Elsevier in International Journal of Cardiology
- Vol. 28, S33-S43
- https://doi.org/10.1016/0167-5273(90)90149-y
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapyAmerican Heart Journal, 1989
- Central and regional hemodynamic effects of oral enoximone in congestive heart failure: A double-blind, placebo-controlled studyAmerican Heart Journal, 1988
- Double-blind crossover comparison of enoximone and placebo in patients with congestive heart failure.Circulation, 1987
- Long-term treatment with oral enoximone for chronic congestive heart failure: The European experienceThe American Journal of Cardiology, 1987
- Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluationThe American Journal of Cardiology, 1987
- A comparison of hemodynamic effects of one-month oral captopril and enoximone treatment for severe congestive heart failureThe American Journal of Cardiology, 1987
- A double-blind dose response comparison of oral enoximone and placebo for congestive heart failureThe American Journal of Cardiology, 1987
- Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement.Circulation, 1985
- Classification of ventricular arrhythmias based on parallel hierarchies of frequency and formThe American Journal of Cardiology, 1984
- Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failureThe American Journal of Cardiology, 1984